Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of N-acetyl-L-leucine in Niemann-Pick disease type C
2018-004331-71Phase 2Completed
- Sponsor
- IntraBio
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levacetylleucine in Niemann-Pick disease type C (NPC), sponsored by IntraBio. Started Jan 2019; status: completed.
02
Drugs
levacetylleucine
03
Conditions
Niemann-Pick disease type C (NPC)
Beyond the preview
Go deeper on 2018-004331-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004331-71.